AXIM Biotechnologies, Inc.
AXIM
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.02M
Close$
Share Statistics
| Market cap | $1.02 Million |
|---|---|
| Enterprise Value | $8.80 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | -0.11 |
| Outstanding Shares | 349,804,452 |
Return
| Return on Equity | 7.30% |
|---|---|
| Return on Assets | -24.88% |
| Return on Invested Capital | 36.82% |
Valuation & Multiples
| P/E Ratio | -1.58 |
|---|---|
| PEG | 0.66 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 22.44 |
| Enterprise Value to EBIT | -8.37 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.89 |
| Debt to Equity | -0.69 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About AXIM Biotechnologies, Inc.
7 employees
CEO: Catalina Valencia AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is curren...